Effects of cilostazol and renin-angiotensin system (RAS) blockers on the renal disease progression of Korean patients: a retrospective cohort study
Conclusion Treatment with cilostazol plus ACEI or ARB was observed to prevent worsening of renal progression in patients in the stages 1 –2.
Source: International Journal of Clinical Pharmacy - Category: Drugs & Pharmacology Source Type: research
More News: Cardiology | Cardiovascular | Cilostazol | Diabetes | Dialysis | Drugs & Pharmacology | Endocrinology | Heart | Heart Attack | Ischemic Stroke | Stroke | Study | Transplants